Pérez-Morales M et al. |
2-AG into the lateral hypothalamus increases REM sleep and cFos expression in melanin concentrating hormone neurons in rats. |
2013 |
Pharmacol. Biochem. Behav. |
pmid:23603032
|
Wakley AA and Rasmussen EB |
Effects of cannabinoid drugs on the reinforcing properties of food in gestationally undernourished rats. |
2009 |
Pharmacol. Biochem. Behav. |
pmid:19602424
|
Stanley CP and O'Sullivan SE |
Cyclooxygenase metabolism mediates vasorelaxation to 2-arachidonoylglycerol (2-AG) in human mesenteric arteries. |
2014 |
Pharmacol. Res. |
pmid:24548820
|
Eisenstein SA et al. |
A role for 2-arachidonoylglycerol and endocannabinoid signaling in the locomotor response to novelty induced by olfactory bulbectomy. |
2010 |
Pharmacol. Res. |
pmid:20044005
|
Deshmukh RR and Sharma PL |
Stimulation of accumbens shell cannabinoid CB(1) receptors by noladin ether, a putative endocannabinoid, modulates food intake and dietary selection in rats. |
2012 |
Pharmacol. Res. |
pmid:22728691
|
Khasabova IA et al. |
JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral neuropathy. |
2014 |
Pharmacol. Res. |
pmid:25304184
|
Navarria A et al. |
The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis. |
2014 |
Pharmacol. Res. |
pmid:24861565
|
Spradley JM et al. |
Inhibitors of monoacylglycerol lipase, fatty-acid amide hydrolase and endocannabinoid transport differentially suppress capsaicin-induced behavioral sensitization through peripheral endocannabinoid mechanisms. |
2010 |
Pharmacol. Res. |
pmid:20416378
|
Leishman E et al. |
Broad impact of deleting endogenous cannabinoid hydrolyzing enzymes and the CB1 cannabinoid receptor on the endogenous cannabinoid-related lipidome in eight regions of the mouse brain. |
2016 |
Pharmacol. Res. |
pmid:27109320
|
Guindon J et al. |
Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment. |
2013 |
Pharmacol. Res. |
pmid:23127915
|
Sciolino NR et al. |
Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats. |
2011 |
Pharmacol. Res. |
pmid:21600985
|
Stefano GB et al. |
2-arachidonyl-glycerol stimulates nitric oxide release from human immune and vascular tissues and invertebrate immunocytes by cannabinoid receptor 1. |
2000 |
Pharmacol. Res. |
pmid:10987990
|
Malek N et al. |
The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain. |
2016 |
Pharmacol. Res. |
pmid:27326920
|
Fowler CJ and Ghafouri N |
Does the hydrolysis of 2-arachidonoylglycerol regulate its cellular uptake? |
2008 |
Pharmacol. Res. |
pmid:18675915
|
Nicolussi S et al. |
Guineensine is a novel inhibitor of endocannabinoid uptake showing cannabimimetic behavioral effects in BALB/c mice. |
2014 |
Pharmacol. Res. |
pmid:24412246
|
Khasabova IA et al. |
Increasing 2-arachidonoyl glycerol signaling in the periphery attenuates mechanical hyperalgesia in a model of bone cancer pain. |
2011 |
Pharmacol. Res. |
pmid:21440630
|
Bakas T et al. |
The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABA receptors. |
2017 |
Pharmacol. Res. |
pmid:28249817
|
Pagano E et al. |
Pharmacological inhibition of MAGL attenuates experimental colon carcinogenesis. |
2017 |
Pharmacol. Res. |
pmid:28193521
|
Straiker A et al. |
Aiming for allosterism: Evaluation of allosteric modulators of CB1 in a neuronal model. |
2015 |
Pharmacol. Res. |
pmid:26211948
|
Imperatore R et al. |
Formation of OX-1R/CB1R heteromeric complexes in embryonic mouse hypothalamic cells: Effect on intracellular calcium, 2-arachidonoyl-glycerol biosynthesis and ERK phosphorylation. |
2016 |
Pharmacol. Res. |
pmid:27436148
|